- For Immediate Release
December 11, 2012 - AUSTIN, TX
- For more information, contact
Chris Cutrone 512-305-8483
CPRIT APPOINTS DR. MARGARET L. KRIPKE AS CHIEF SCIENTIFIC OFFICER
The Cancer Prevention and Research Institute of Texas (CPRIT) today announced the appointment of Dr. Margaret L. Kripke to the position of chief scientific officer, where she will be responsible for overseeing the Institute’s Research portfolio. Historically, CPRIT’s Research portfolio has funded the majority of the Institute’s $300 million in annual grant awards, and is the second largest funding source for cancer-related research in the U.S. CPRIT’s other portfolios include Prevention, which focuses on reducing cancer incidence among Texans utilizing the latest proven methodologies, and Commercialization, which centers on efforts to quickly get lifesaving products to Texans battling the disease.
Dr. Kripke retired in 2007 from The University of Texas MD Anderson Cancer Center where she was the executive vice president and chief academic officer. While there, she founded the Department of Immunology and was also a professor of immunology. She recently completed a nine-year term on the three-person President’s Cancer Panel, an honor reserved for the most distinguished oncology scientists in the nation.
"Dr. Kripke’s global reputation as a leading oncology researcher is nothing short of outstanding, and we’re honored to have her join the CPRIT team,” said Dr. Joseph Bailes, vice chairman of CPRIT’s Oversight Committee and chair of the Chief Scientific Officer Search Committee. “Dr. Kripke’s stature in the oncology community makes her the perfect fit to build on what CPRIT has achieved to date. With her leadership, we can continue to select and fund the best projects with the most promise for ending cancer, once and for all."
Dr. Kripke holds a PhD in Immunology from the University of California at Berkeley and is a world-renowned expert in the immunology of skin cancers. Due to her esteemed position within the scientific community, particularly as a champion of diversity in the workplace, the Margaret L. Kripke Legend Award was established by MD Anderson in 2008 to honor individuals who have enhanced the careers of women in cancer medicine and cancer science.
"The opportunity created by CPRIT to advance cancer research, prevention and treatment and to put Texas at the forefront of these fields is unparalleled," said Dr. Kripke about her appointment. "I am honored to be able to participate in this endeavor."
Dr. Kripke will join CPRIT on Jan. 7, 2013.
Texas voters overwhelmingly approved a constitutional amendment in 2007 establishing CPRIT and authorizing the state to issue $3 billion in bonds to fund groundbreaking cancer research and prevention programs and services in Texas. CPRIT’s goal is to expedite innovation and commercialization in the area of cancer research and to enhance access to evidence-based prevention programs and services throughout the state. CPRIT accepts applications and awards grants for a wide variety of cancer-related research and for the delivery of cancer prevention programs and services by public and private entities located in Texas. More information about CPRIT is available on its website, www.cprit.state.tx.us.